Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Citi
Boehringer Ingelheim
Chinese Patent Office
Express Scripts
Colorcon

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 5,886,148

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,886,148
Title: Parathyroid hormone receptor
Abstract:DNA encoding a parathyroid hormone receptor; production and isolation of recombinant and synthetic parathyroid hormone receptor polypeptides and fragments; antibodies to parathyroid hormone receptors and receptor fragments; methods for screening candidate compounds for antagonistic or agonistic effects on parathyroid hormone receptor action; and diagnostic and therapeutic methods of these compounds are disclosed.
Inventor(s): Segre; Gino V. (Wayland, MA), Kronenberg; Henry M. (Belmont, MA), Abou-Samra; Abdul-Badi (Plainville, MA), Juppner; Harald (Boston, MA), Potts, Jr.; John T. (West Newton, MA), Schipani; Ernestina (Boston, MA)
Assignee: The General Hospital Corporation (Boston, MA)
Application Number:08/468,249
Patent Claims:see list of patent claims

Details for Patent 5,886,148

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ➤ Sign Up The General Hospital Corporation (Boston, MA) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ➤ Sign Up The General Hospital Corporation (Boston, MA) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ➤ Sign Up The General Hospital Corporation (Boston, MA) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23 ➤ Sign Up The General Hospital Corporation (Boston, MA) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 5,886,148

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 9217602 Oct 15, 1992
United States of America 2003153041 Aug 14, 2003
United States of America 5261686 Nov 16, 1993
United States of America 5494806 Feb 27, 1996
United States of America 5840853 Nov 24, 1998
United States of America 7132260 Nov 07, 2006
United States of America 7150974 Dec 19, 2006
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
AstraZeneca
Chubb
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.